The combination of the p38 MAPK inhibitor ARRY-614 plus nivolumab with or without ipilimumab was well…
Tag: immuno-oncology
At Last, Artificial Intelligence Is Transforming Cancer Drug Discovery and Development
Having spent more than 3 decades as a hematology/oncology researcher and physician, it is invigorating to…
Compass Therapeutics Announces Clinical Collaboration with
BOSTON, Oct. 11, 2022 (GLOBE NEWSWIRE) — Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage biopharmaceutical company…
